NEW YORK (GenomeWeb News) – As expected, Invitrogen and Applied Biosystems have completed their $6.7 billion merger today, Invitrogen announced.
 
The combined company will be called Life Technologies and will begin trading on the Nasdaq exchange under the symbol “LIFE” on Monday, Nov. 24.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.